Mmbg Investment Advisors Co. Moderna, Inc. Transaction History

Mmbg Investment Advisors Co.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$118.38 - $210.04 $169,283 - $300,357	-1,430 Reduced 33.33%	2,860 $514,000
Q2 2022 Aug 02, 2022	BUY	$117.13 - $176.59 $167,495 - $252,523	1,430 Added 50.0%	4,290 $613,000
Q1 2022 Aug 02, 2022	SELL	$126.46 - $235.05 $354,593 - $659,080	-2,804 Reduced 49.51%	2,860 $493,000
Q1 2022 May 06, 2022	BUY	$126.46 - $235.05 $354,593 - $659,080	2,804 Added 98.04%	5,664 $325,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $645,845 - $1.05 Million	2,860 New	2,860 $726,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mmbg Investment Advisors Co., based on Form 13F filings with the SEC.

Stay updated on Mmbg Investment Advisors Co. with notifications on news.